Products are sold solely for research and development purposes.
The goal is to make sure BPC-157 is the right tool for your situation and that it is administered in a way that maximizes both safety and efficacy
Mast Cell Activation Syndrome Treatment Conventional treatment for mast cell activation syndrome generally involves the use of pharmaceutical and over-the-counter medications to alleviate symptoms, such as the following medications: Epinephrine (such as an EpiPen) for severe reactions First generation H1 blockers diphenhydramine (Benadryl) and hydroxyzine (Vistaril) Second generation H1 blockers, including loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) H2 blockers, such as ranitidine (Zantac) and famotidine (Pepcid) Aspirin, to block production of prostaglandin D2 and reduce flushing
Joint and bone health GH and IGF-1 are critical for maintaining connective tissue and skeletal health
Targeted photoredox catalysis in cancer cells
By promoting the mobilization and use of fat as energy, Choline assists in reducing overall body fat, making it an essential component of the MIC injection